Preventing Occurrence of Microalbuminuria in Type 2 Diabetes

Data presented at Renal Week 2009 demonstrate that an angiotensin receptor blocker—olmesartan—appears to provide vascular protection in patients with type 2 diabetes by controlling blood pressure and delaying the occurrence of...

Read More